recombinant human IL-2 (low-dose)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for recombinant human IL-2 (low-dose), covering 2019-09-09 to 2019-09-09. Get the full timeline:
Most recent: Clinical Trial Update: Low-dose Recombinant Human IL-2 for the Treatment of Rheumatoid Arthritis [Phase 2]